Bracco Diagnostics
RELATED CONTENT
The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals to stop using CardioGen-82 for cardiac positron emission tomography (PET) scans. The manufacturer, Bracco Diagnostics Inc., has decided to voluntarily recall CardioGen-82 this week after two patients set off radiation detectors at a U.S. border crossings due to strontium contamination.
July 26, 2011 
Despite its first commercial appearance in the late 1970s, positron emission tomograpnhy (PET) did not begin gaining widespread acceptance as a viable clinical technology until the mid-1990s. This was after it gained approval for reimbursement and radiopharmaceuticals for PET became more widely available.
July 18, 2011
December 16, 2010 – Bracco Imaging demonstrated how its customized evidence-based diagnostic imaging solutions are meeting the demands of an evolving radiology market at the Radiological Society of North America (RSNA) meeting.
December 16, 2010
Bracco offers contrast imaging agents for computed tomography (CT), magnetic resonance imaging (MRI), angiography and ...
October 27, 2010
October 19, 2010 — CardioGen-82 (Rubidium Rb 82 Generator) when used with positron emission tomography (PET) myocardial perfusion imaging (MPI) has been shown to produce “reasonably low radiation exposure” of 3.7mSv for a complete rest/stress study. 1
October 19, 2010
June 14, 2010 – A radio tracer is quickly gaining popularity among cardiologists in the United States.
June 14, 2010
Automated contrast media injectors are used in cardiac imaging to help improve patient safety and enhance image quality. These devices can control contrast dosage, record the amount used, speed injections to keep up with faster computed tomography (CT) scanners, and warn clinicians of potential hazards, such as air embolisms or extravasations.
June 02, 2010
The biggest challenge in applying best practices in radiology workflow is seeing the big picture. The entire imaging cycle includes identifying the patient data, conducting the imaging exam according to the proper protocols, and then streamlining and processing the data in a timely manner.
March 31, 2010
Bracco Diagnostics and Acist Medical Systems featured the EmpowerCTA contrast injector, updated with integrated, pre-programmed multislice CT protocols for IsoVue-370 (iopamidol injection)
December 11, 2009
Robert G. Mitchell, senior manager, contrast imaging solutions, explains how Bracco Diagnostics' acquisition of E-Z-EM further positions the company as a global leader in diagnostic imaging in radiology and cardiology. The merger allows for significant growth opportunities as E-Z-EM complements Bracco's comprehensive repertoire of diagnostic imaging agents.
December 09, 2009
